The chart below shows how NNOX performed 10 days before and after its earnings report, based on data from the past quarters. Typically, NNOX sees a +3.00% change in stock price 10 days leading up to the earnings, and a -7.43% change 10 days following the report. On the earnings day itself, the stock moves by +4.08%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Quarterly Revenue Increase: The company reported a revenue of $3.0 million for the third quarter of 2024, showing an increase compared to $2.5 million in the same period last year.
Tele-Radiology Revenue and Profit: The tele-radiology services generated $2.6 million in revenue, with a gross profit of $0.3 million, representing a gross profit margin of approximately 15%.
Tele-Radiology Revenue Surge: The company generated $2.6 million in revenues from its tele-radiology services, which is a significant increase from the previous year.
ARC Tube Assembly Completion: The company has successfully completed the assembly of the first ARC tubes with NanoX proprietary emitters, ready for shipment from their manufacturing facility.
Strong Financial Position: The company ended the third quarter of 2024 with a net cash position of approximately $57.1 million, indicating strong financial health.
Negative
Quarterly Net Loss Comparison: Reported a GAAP net loss for the third quarter of 2024 of $13.6 million, compared to a net loss of $21.4 million in the third quarter of 2023, indicating ongoing financial challenges.
Net Loss Decrease Factors: The decrease in net loss was largely due to an increase of $7.4 million in expenses related to impairment of goodwill, highlighting significant operational costs.
Revenue Decline Analysis: Revenue for the reported period was $3.0 million, with a gross loss of $2.8 million on a GAAP basis, reflecting poor revenue generation.
Gross Loss Decline: Non-GAAP gross loss for the reported period was $0.2 million, compared to a non-GAAP gross profit of $0.9 million in the comparable period, indicating a decline in profitability.
R&D Expense Decrease: Research and development expenses net for the reported period were $4.7 million, compared to $6.0 million in the comparable period, showing a decrease in investment in innovation.
Nano-X Imaging Ltd. (NNOX) Q3 2024 Earnings Call Transcript
NNOX.O
-3.54%